Recent update on the pharmacological effects and mechanisms of dihydromyricetin

J Zhang, Y Chen, H Luo, L Sun, M Xu, J Yu… - Frontiers in …, 2018 - frontiersin.org
As the most abundant natural flavonoid in rattan tea, dihydromyricetin (DMY) has shown a
wide range of pharmacological effects. In addition to the general characteristics of …

Dihydromyricetin: A review on identification and quantification methods, biological activities, chemical stability, metabolism and approaches to enhance its …

D Liu, Y Mao, L Ding, XA Zeng - Trends in Food Science & Technology, 2019 - Elsevier
Background Dihydromyricetin (DMY) is an important plant flavonoid, which has received
great attention due to its health-benefiting activities, including antioxidant, antimicrobial, anti …

Targeting PI3K/Akt/mTOR signaling pathway by polyphenols: Implication for cancer therapy

M Mirza-Aghazadeh-Attari, EM Ekrami, SAM Aghdas… - Life sciences, 2020 - Elsevier
Cancer is one of the biggest challenges facing medicine and its cure is regarded to be the
Holy Grail of medicine. Therapy in cancer is consisted as various artificial cytotoxic agents …

A comprehensive review of vine tea: Origin, research on Materia Medica, phytochemistry and pharmacology

T Zeng, Y Song, S Qi, R Zhang, L Xu, P Xiao - Journal of …, 2023 - Elsevier
Ethnopharmacological relevance Vine tea is a popular folk tea that has been consumed in
China for more than 1200 years. It is often used in ethnic medicine by ethnic groups in …

[HTML][HTML] Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease

J Chen, X Wang, T Xia, Y Bi, B Liu, J Fu… - Biomedicine & …, 2021 - Elsevier
Recent studies demonstrated that dihydromyricetin (DHM) has prominent therapeutic effects
on liver injury and liver cancer. By summarizing the current preclinical in vitro and in vivo …

The versatile effects of dihydromyricetin in health

H Li, Q Li, Z Liu, K Yang, Z Chen… - Evidence‐Based …, 2017 - Wiley Online Library
Dihydromyricetin is a flavonoid isolated from Ampelopsis grossedentata, which is
traditionally used in China. Dihydromyricetin exhibits health‐benefiting activities with …

Targeting mTOR as a cancer therapy: Recent advances in natural bioactive compounds and immunotherapy

A Bouyahya, A El Allam, S Aboulaghras, S Bakrim… - Cancers, 2022 - mdpi.com
The mammalian target of rapamycin (mTOR) is a highly conserved serine/threonine-protein
kinase, which regulates many biological processes related to metabolism, cancer, immune …

A deep insight into mechanism for inclusion of 2R, 3R-dihydromyricetin with cyclodextrins and the effect of complexation on antioxidant and lipid-lowering activities

Y Wu, Y Xiao, Y Yue, K Zhong, Y Zhao, H Gao - Food Hydrocolloids, 2020 - Elsevier
Abstract 2R, 3R-Dihydromyricetin (DMY) is a natural flavonoid that has versatile biological
activities. However, due to its poor water solubility and low chemical stability, its applications …

Dihydromyricetin modulates p62 and autophagy crosstalk with the Keap-1/Nrf2 pathway to alleviate ethanol-induced hepatic injury

P Qiu, Y Dong, B Li, X Kang, C Gu, T Zhu, Y Luo… - Toxicology letters, 2017 - Elsevier
Increasing evidence has demonstrated that dihydromyricetin (DMY) contains highly effective
antioxidative, anti-inflammatory, anti-microbial and anti-diabetic properties. Nevertheless …

Present status, challenges, and prospects of dihydromyricetin in the battle against cancer

J Wu, Z Xiao, H Li, N Zhu, J Gu, W Wang, C Liu… - Cancers, 2022 - mdpi.com
Simple Summary With the advancements in diagnosis and treatment technology, the
mortality of patients with cancer is gradually decreasing. However, further curbing cancer …